[go: up one dir, main page]

DK1072198T3 - Præparat til anvendelse som medikament og/eller ernæringstilskud - Google Patents

Præparat til anvendelse som medikament og/eller ernæringstilskud

Info

Publication number
DK1072198T3
DK1072198T3 DK99810681T DK99810681T DK1072198T3 DK 1072198 T3 DK1072198 T3 DK 1072198T3 DK 99810681 T DK99810681 T DK 99810681T DK 99810681 T DK99810681 T DK 99810681T DK 1072198 T3 DK1072198 T3 DK 1072198T3
Authority
DK
Denmark
Prior art keywords
drug
preparation
nutritional supplement
complex
free
Prior art date
Application number
DK99810681T
Other languages
English (en)
Inventor
Dieter Wolfgang Engel
Georg Dr Kokkinis
Original Assignee
Swiss Caps Rechte & Lizenzen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Swiss Caps Rechte & Lizenzen filed Critical Swiss Caps Rechte & Lizenzen
Application granted granted Critical
Publication of DK1072198T3 publication Critical patent/DK1072198T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A23L33/165—Complexes or chelates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Inorganic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK99810681T 1999-07-28 1999-07-28 Præparat til anvendelse som medikament og/eller ernæringstilskud DK1072198T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99810681A EP1072198B1 (de) 1999-07-28 1999-07-28 Präparat zur Verwendung als Medikament und/oder Nahrungsmittelergänzung

Publications (1)

Publication Number Publication Date
DK1072198T3 true DK1072198T3 (da) 2008-09-22

Family

ID=8242947

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99810681T DK1072198T3 (da) 1999-07-28 1999-07-28 Præparat til anvendelse som medikament og/eller ernæringstilskud

Country Status (8)

Country Link
US (1) US6368621B1 (da)
EP (1) EP1072198B1 (da)
JP (1) JP2001089380A (da)
AT (1) ATE394941T1 (da)
DE (1) DE59914760D1 (da)
DK (1) DK1072198T3 (da)
ES (1) ES2304061T3 (da)
PT (1) PT1072198E (da)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7201923B1 (en) 1998-03-23 2007-04-10 General Mills, Inc. Encapsulation of sensitive liquid components into a matrix to obtain discrete shelf-stable particles
AU747549B2 (en) 1998-03-23 2002-05-16 General Mills Inc. Encapsulation of components into edible products
GB9901809D0 (en) * 1999-01-27 1999-03-17 Scarista Limited Highly purified ethgyl epa and other epa derivatives for psychiatric and neurological disorderes
US20050037065A1 (en) * 1999-05-27 2005-02-17 Drugtech Corporation Nutritional formulations
US6500463B1 (en) 1999-10-01 2002-12-31 General Mills, Inc. Encapsulation of sensitive components into a matrix to obtain discrete shelf-stable particles
US6558718B1 (en) 2000-06-19 2003-05-06 General Mills, Inc. Nutrient clusters for food products and methods of preparation
US20030060509A1 (en) * 2001-08-24 2003-03-27 Elswyk Mary Van Products containing highly unsaturated fatty acids for use by women and their children during stages of preconception, pregnancy and lactation/post-partum
US7704542B2 (en) * 2001-09-12 2010-04-27 Xanodyne Pharmaceuticals, Inc. Vitamin/mineral compositions with DHA
FR2829692B1 (fr) * 2001-09-17 2004-10-15 Lehning Lab Composition selective de six categories de substances preservant l'equilibre physiologique chez l'homme comprenant un complexe de micronutriments,un complexe d'antioxydants et un complexe d'acides gras.
WO2003043570A2 (en) * 2001-11-15 2003-05-30 Galileo Laboratories, Inc. Formulations and methods for treatment or amelioration of inflammatory conditions
US20030228392A1 (en) * 2002-06-06 2003-12-11 Wyeth Infant formula compositions containing lutein and zeaxanthin
US7431986B2 (en) * 2002-07-24 2008-10-07 General Mills, Inc. Encapsulation of sensitive components using pre-emulsification
US8088363B2 (en) 2002-10-28 2012-01-03 Zeavision Llc Protection against sunburn and skin problems with orally-ingested high-dosage zeaxanthin
US20040213857A1 (en) * 2003-04-17 2004-10-28 Boehringer Ingelheim International Gmbh Multi-vitamin and mineral supplement for pregnant women
EP1670324A1 (en) * 2003-09-26 2006-06-21 Nestec S.A. Nutritional composition with unsaturated fatty acids and trace elements
WO2005063231A2 (en) * 2003-12-31 2005-07-14 Igennus Limited Formulation containing an eicosapentaenoic acid or an ester thereof and a triterpene or esther thereof
DE102004022461B4 (de) 2004-05-06 2006-07-06 Forschungszentrum Rossendorf E.V. Metallkomplexe auf der Basis von Tetrathiol-Liganden und deren Anwendung in der nuklearmedizinischen Diagnostik und Endoradionuklidtherapie sowie Verfahren zur Herstellung der Metallkomplexe
DE102004029697B4 (de) * 2004-06-15 2008-05-15 Ernst-Moritz-Arndt-Universität Greifswald 2-Amino- und 2-Hydroxy-2-phosphinoalkansäure-Derivate und 2-Phosphoniobis(2-hydroxyalkansäure)-Derivate, Verfahren zur Herstellung dieser Derivate und Verwendung der Derivate zur Herstellung von 2-Amino- oder 2-Hydroxyphosphinoalkanoat-Nickel-Derivaten
CA2572650A1 (en) * 2004-07-05 2006-01-12 Solvias Ag Tetradentate ferrocene ligands and their use
US20060217385A1 (en) * 2005-03-10 2006-09-28 Edwards John B Nutritional preparations
BRPI0612915A2 (pt) * 2005-05-19 2010-12-07 Unilever Nv produto nutricional e processo para fabricar um produto nutricional
ES2380952T3 (es) * 2005-10-11 2012-05-21 Bayer Consumer Care Ag Mezcla de sales de hierro y cobre que enmascaran el sabor metálico.
US7803413B2 (en) 2005-10-31 2010-09-28 General Mills Ip Holdings Ii, Llc. Encapsulation of readily oxidizable components
EP1790356A1 (de) * 2005-11-24 2007-05-30 Vifor (International) Ag Präparat, umfassend Eisen(III)-Komplexverbindungen und redoxaktive Substanz(en)
ES2395862T3 (es) * 2006-09-28 2013-02-15 Bayer Consumer Care Ag Mezcla de sales de hierro y de cobre para enmascarar el sabor metálico
US8389504B2 (en) * 2008-05-08 2013-03-05 Mead Johnson Nutrition Company Prenatal dietary supplement
WO2010011712A1 (en) * 2008-07-22 2010-01-28 General Mills, Inc. Fruit products containing omega-3 fatty acids
EP3578177A1 (en) 2008-09-02 2019-12-11 Amarin Pharmaceuticals Ireland Limited Pharmaceutical composition comprising eicosapentaenoic acid and nicotinic acid and methods of using same
ES2769926T3 (es) 2009-02-10 2020-06-29 Amarin Pharmaceuticals Ie Ltd Ester etílico del ácido eicosapentaenoico para tratar la hipertrigliceridemia
MX2011011517A (es) 2009-04-29 2012-06-19 Amarin Corp Plc Composiciones farmaceuticas que comprenden epa y un agente cardiovascular y metodos para utilizar el mismo.
CN102458109B (zh) 2009-04-29 2015-02-11 阿马里纳制药公司 稳定的药物组合物和使用其的方法
CA2762824C (en) * 2009-06-05 2017-10-10 General Mills, Inc. Encapsulated omega-3 fatty acids for baked goods production
LT2443246T (lt) 2009-06-15 2018-03-26 Amarin Pharmaceuticals Ireland Limited Kompozicijos ir būdai, skirti trigliceridų sumažinimui, nepakeliant ldl-c lygio subjekte, kartu taikant statino terapiją
US20110071176A1 (en) 2009-09-23 2011-03-24 Amarin Pharma, Inc. Pharmaceutical composition comprising omega-3 fatty acid and hydroxy-derivative of a statin and methods of using same
US20110218243A1 (en) * 2010-03-04 2011-09-08 Amarin Pharma, Inc. Compositions and methods for treating and/or preventing cardiovascular disease
US11712429B2 (en) 2010-11-29 2023-08-01 Amarin Pharmaceuticals Ireland Limited Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
AU2011336856A1 (en) 2010-11-29 2013-07-04 Amarin Pharmaceuticals Ireland Limited Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
US20130131170A1 (en) 2011-11-07 2013-05-23 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
US11291643B2 (en) 2011-11-07 2022-04-05 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
WO2013103958A1 (en) 2012-01-06 2013-07-11 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering levels of high-sensitivity (hs-crp) in a subject
BR112014032905B1 (pt) 2012-06-29 2022-02-22 Amarin Pharmaceuticals Ireland Limited Uso de éster etílico do ácido eicosapentaenóico para redução do risco de morte cardiovascular, revascularização coronária e/ou angina instável em um indivíduo em terapia com estatina
US20150265566A1 (en) 2012-11-06 2015-09-24 Amarin Pharmaceuticals Ireland Limited Compositions and Methods for Lowering Triglycerides without Raising LDL-C Levels in a Subject on Concomitant Statin Therapy
US20140187633A1 (en) 2012-12-31 2014-07-03 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis
US9814733B2 (en) 2012-12-31 2017-11-14 A,arin Pharmaceuticals Ireland Limited Compositions comprising EPA and obeticholic acid and methods of use thereof
US9452151B2 (en) 2013-02-06 2016-09-27 Amarin Pharmaceuticals Ireland Limited Methods of reducing apolipoprotein C-III
US9624492B2 (en) 2013-02-13 2017-04-18 Amarin Pharmaceuticals Ireland Limited Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof
US9662307B2 (en) 2013-02-19 2017-05-30 The Regents Of The University Of Colorado Compositions comprising eicosapentaenoic acid and a hydroxyl compound and methods of use thereof
US9283201B2 (en) 2013-03-14 2016-03-15 Amarin Pharmaceuticals Ireland Limited Compositions and methods for treating or preventing obesity in a subject in need thereof
US20140271841A1 (en) 2013-03-15 2014-09-18 Amarin Pharmaceuticals Ireland Limited Pharmaceutical composition comprising eicosapentaenoic acid and derivatives thereof and a statin
US10966968B2 (en) 2013-06-06 2021-04-06 Amarin Pharmaceuticals Ireland Limited Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof
US20150065572A1 (en) 2013-09-04 2015-03-05 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing prostate cancer
US9585859B2 (en) 2013-10-10 2017-03-07 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
US9492421B1 (en) 2013-11-14 2016-11-15 Argent Development Group, Llc Nutritional supplements for treatment of iron deficiency anemia
US9629846B1 (en) 2013-11-14 2017-04-25 Argent Development Group, Llc Nutritional supplements for women desiring to become pregnant, and pregnant and nursing women
GB201404390D0 (en) * 2014-03-12 2014-04-23 Iron Therapeutics Holdings Ag Composition
WO2015185698A1 (en) 2014-06-04 2015-12-10 Dignity Sciences Limited Pharmaceutical compositions comprising dgla and use of same
US10561631B2 (en) 2014-06-11 2020-02-18 Amarin Pharmaceuticals Ireland Limited Methods of reducing RLP-C
US10172818B2 (en) 2014-06-16 2019-01-08 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
US10406130B2 (en) 2016-03-15 2019-09-10 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
CN109982586A (zh) * 2016-12-15 2019-07-05 雀巢产品技术援助有限公司 包含铁-酪蛋白络合物和对氧化敏感的化合物的呈粉末形式的组合物
WO2018213663A1 (en) 2017-05-19 2018-11-22 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides in a subject having reduced kidney function
US11058661B2 (en) 2018-03-02 2021-07-13 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy and having hsCRP levels of at least about 2 mg/L
MA51766A (fr) 2018-09-24 2020-12-16 Amarin Pharmaceuticals Ie Ltd Procédés de réduction du risque d'événements cardiovasculaires chez un sujet
JP6517997B1 (ja) * 2018-12-21 2019-05-22 株式会社ファンケル ビタミンｅ含有油性組成物
CN114980973A (zh) 2019-11-12 2022-08-30 阿马里纳药物爱尔兰有限公司 降低心房纤颤和/或心房扑动受试者心血管事件风险的方法
US20210315851A1 (en) 2020-04-03 2021-10-14 Afimmune Limited Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseases
AU2022263358A1 (en) 2021-04-21 2023-11-30 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of heart failure

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3392177A (en) * 1965-10-13 1968-07-09 Agriculture Usa Conjugation of vegetable oils via iron tricarbonyl complex and decomposition thereofby carbon monoxide
DE2623486C2 (de) * 1976-05-26 1982-12-30 Hoechst Ag, 6000 Frankfurt 3.5.5-Trimethylhexanoyl-ferrocen, Verfahren zu seiner Herstellung und pharmazeutische Präparate
DE2639177A1 (de) * 1976-08-31 1978-03-02 Hohenester Hermann Verfahren zur herstellung diaetetischer fleischpasteten mit geringem fettgehalt
DE3365971D1 (en) * 1982-03-24 1986-10-16 Nat Res Dev Pharmaceutical compositions containing a complex of iron with n-substituted 3-hydroxypyrid-2-one or -4-one derivatives
GB2128998B (en) * 1982-10-22 1986-07-16 Nat Res Dev Pharmaceutical compositions of iron complexes of 3 hydroxy-4-pyrone
NL8403433A (nl) * 1984-11-09 1986-06-02 Holland Melkunie Voedingssuppletiepreparaat op basis van melkbestanddelen.
IL80783A0 (en) * 1986-10-17 1987-02-27 Univ Bar Ilan Food supplements
US5120763A (en) * 1986-11-26 1992-06-09 Bar Ilan University Physiologically active and nutritional composition
JPH0367571A (ja) * 1989-08-07 1991-03-22 Kansai Paint Co Ltd 鉄分強化清涼飲料水
ES2033193B1 (es) * 1990-10-30 1994-01-16 Ganadera Union Ind Agro Mezcla grasa para nutricion infantil y de adultos.
GB2254556B (en) * 1991-04-11 1995-04-12 Fisons Plc Formulations containing linolenic acid

Also Published As

Publication number Publication date
DE59914760D1 (de) 2008-06-26
JP2001089380A (ja) 2001-04-03
ES2304061T3 (es) 2008-09-01
US6368621B1 (en) 2002-04-09
PT1072198E (pt) 2008-06-17
EP1072198B1 (de) 2008-05-14
EP1072198A1 (de) 2001-01-31
ATE394941T1 (de) 2008-05-15

Similar Documents

Publication Publication Date Title
DK1072198T3 (da) Præparat til anvendelse som medikament og/eller ernæringstilskud
ZA200200259B (en) Pharmaceutical and nutritional compositions containing essential fatty acids and homocysteine-lowering agents.
DK0956013T3 (da) Farmaceutisk præparat indeholdende eicosapentaensyre og/eller stearidonsyre
DE60000133D1 (de) Essentielle fettsäuren zur vorbeugung von kardiovaskulären anfällen
HUP0303817A3 (en) Medium-chain length fatty acids, glycerides and analogues as neutrophile survival and activation factors and pharmaceutical compositions containing them
PL307990A1 (en) Cosmetical; and/or dermatological composition with hydrophilous carrier and vitamin c, to be shaken immediately before use
EP2218342A3 (en) Novel nutraceutical compositions and use thereof
CA2315784A1 (en) Tts containing an antioxidant
IL158131A0 (en) Methods, compounds, and compositions for reducing body fat and modulating fatty acid metabolism
MY104412A (en) Acne treatment.
HRP20010684B1 (hr) Izravno stlaciva matrica za kontrolirano otpustanje jednostruke dnevne doze klaritromicina
EE05491B1 (et) Leeliselist sfingomelinaasi sisaldav kompositsioon kasutamiseks dieteetilise valmistise, toidulisandi v?i farmatseutilise tootena
AU2001232238A1 (en) Anti-acid-fast bacterial agents containing pyridonecarboxylic acids as the active ingredient
WO2003018064A3 (en) Lipophilic drug compositions
NO20031876D0 (no) Medikamentpreparater på granulatform inneholdende forgrenede aninosyrer ogfremgangsmåter for fremstilling derav
IL86395A0 (en) Pharmaceutical compositions containing flunarizine
HU9303230D0 (en) Use of lanoline derivatives for promotion of transdermal resorption of drugs and other biological substances
ATE75395T1 (de) Linolensaeuren enthaltende pharmazeutische und diaet-zusammensetzungen zur behandlung von gutartiger prostatahypertrophie.
WO2001085188A3 (en) Use of echinacea as a hematinic agent
CA2335713A1 (en) Oral dosage form
ID19912A (id) Asam-asam dikarboksilat sebagai bahan makanan hewan
AU6524298A (en) Pharmaceutical composition, containing medium-chain fatty acids as active ingredients, for dental caries and periodontal disease
FR2829692B1 (fr) Composition selective de six categories de substances preservant l'equilibre physiologique chez l'homme comprenant un complexe de micronutriments,un complexe d'antioxydants et un complexe d'acides gras.
WO1999051740A3 (en) Nucleotide sequence expressing human fatty acid transport protein and corresponding aminoacid, use for the regulation of fatty acids metabolism
DK0991741T3 (da) Voksestere, som er beriget med omega-3-umættede fedtsyrer, deres fremstilling og anvendelse